Matches in SemOpenAlex for { <https://semopenalex.org/work/W3120417475> ?p ?o ?g. }
- W3120417475 endingPage "1369" @default.
- W3120417475 startingPage "1363" @default.
- W3120417475 abstract "There are limited data on the neutralizing activity of convalescent plasma (CP) administered in randomized controlled trials (RCT) of COVID-19 infection.As part of an RCT, CP was collected per FDA guidelines from individuals recovered from COVID-19 infection. CP donors had to have ≥145 optical density (OD) units (ideal target ≥300) using a semiquantitative, immunochromatographic test for IgG antibody to the nucleocapsid protein (NP) of SARS-CoV-2 (typical range 0-500 OD units). A random subset of samples [14 control plasma, 12 CP medium-anti-NP (145-299 OD units), and 13 CP high anti-NP (≥300 OD units)] were tested for neutralizing antibodies using an established viral luciferase antibody inhibition assay to detect the infection of SARS-CoV-2 pseudovirus that encoded spike protein (SARS2-Strunc ) on a human immunodeficiency virus 1 vector (NL43dEnvNanoLuc), using ACE2-expressing 293 T cells. The titer needed to neutralize 50% of viral activity (NT50) was calculated.The uptake of SARS-CoV-2 pseudovirus by 293TACE2 cells was inhibited by pretreatment with CP compared to control CP (p < .001) with control plasma having a median (IQR) 50% neutralization titer (NT50) of 1:28 (1:16,1:36) compared to 1:334 (1:130,1:1295) and 1:324 (1:244,1:578), for medium anti-NP and high anti-NP CP units, respectively. The neutralizing activity of CP met minimum FDA criteria with neutralizing antibody titers >1:80 in 100% of randomly selected samples, using a conservative approach that excluded non-specific binding.Plasma from donors screened using an immunochromatographic test for IgG antibody to SARS-CoV-2 NP exhibited neutralizing activity meeting FDA's minimum standard in all randomly selected COVID-19 CP units." @default.
- W3120417475 created "2021-01-18" @default.
- W3120417475 creator A5001960560 @default.
- W3120417475 creator A5007287741 @default.
- W3120417475 creator A5042512615 @default.
- W3120417475 creator A5042786939 @default.
- W3120417475 creator A5065367982 @default.
- W3120417475 creator A5076394795 @default.
- W3120417475 creator A5080361115 @default.
- W3120417475 creator A5086099448 @default.
- W3120417475 creator A5088652167 @default.
- W3120417475 date "2021-02-19" @default.
- W3120417475 modified "2023-10-16" @default.
- W3120417475 title "Neutralizing activity to <scp>SARS‐CoV</scp>‐2 of convalescent and control plasma used in a randomized controlled trial" @default.
- W3120417475 cites W2148822770 @default.
- W3120417475 cites W2772039551 @default.
- W3120417475 cites W3012756997 @default.
- W3120417475 cites W3015281372 @default.
- W3120417475 cites W3020828664 @default.
- W3120417475 cites W3021816206 @default.
- W3120417475 cites W30316958 @default.
- W3120417475 cites W3032394272 @default.
- W3120417475 cites W3036386821 @default.
- W3120417475 cites W3043033641 @default.
- W3120417475 cites W3044702419 @default.
- W3120417475 cites W3048799641 @default.
- W3120417475 cites W3084653951 @default.
- W3120417475 cites W3092751654 @default.
- W3120417475 cites W3093120161 @default.
- W3120417475 cites W3093711492 @default.
- W3120417475 cites W3106654302 @default.
- W3120417475 cites W3117382778 @default.
- W3120417475 cites W3120417475 @default.
- W3120417475 doi "https://doi.org/10.1111/trf.16283" @default.
- W3120417475 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8014203" @default.
- W3120417475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33448402" @default.
- W3120417475 hasPublicationYear "2021" @default.
- W3120417475 type Work @default.
- W3120417475 sameAs 3120417475 @default.
- W3120417475 citedByCount "8" @default.
- W3120417475 countsByYear W31204174752021 @default.
- W3120417475 countsByYear W31204174752022 @default.
- W3120417475 countsByYear W31204174752023 @default.
- W3120417475 crossrefType "journal-article" @default.
- W3120417475 hasAuthorship W3120417475A5001960560 @default.
- W3120417475 hasAuthorship W3120417475A5007287741 @default.
- W3120417475 hasAuthorship W3120417475A5042512615 @default.
- W3120417475 hasAuthorship W3120417475A5042786939 @default.
- W3120417475 hasAuthorship W3120417475A5065367982 @default.
- W3120417475 hasAuthorship W3120417475A5076394795 @default.
- W3120417475 hasAuthorship W3120417475A5080361115 @default.
- W3120417475 hasAuthorship W3120417475A5086099448 @default.
- W3120417475 hasAuthorship W3120417475A5088652167 @default.
- W3120417475 hasBestOaLocation W31204174751 @default.
- W3120417475 hasConcept C126322002 @default.
- W3120417475 hasConcept C14086860 @default.
- W3120417475 hasConcept C159047783 @default.
- W3120417475 hasConcept C159654299 @default.
- W3120417475 hasConcept C203014093 @default.
- W3120417475 hasConcept C2779134260 @default.
- W3120417475 hasConcept C2779261636 @default.
- W3120417475 hasConcept C3007834351 @default.
- W3120417475 hasConcept C3008058167 @default.
- W3120417475 hasConcept C3018027319 @default.
- W3120417475 hasConcept C32611913 @default.
- W3120417475 hasConcept C524204448 @default.
- W3120417475 hasConcept C71924100 @default.
- W3120417475 hasConceptScore W3120417475C126322002 @default.
- W3120417475 hasConceptScore W3120417475C14086860 @default.
- W3120417475 hasConceptScore W3120417475C159047783 @default.
- W3120417475 hasConceptScore W3120417475C159654299 @default.
- W3120417475 hasConceptScore W3120417475C203014093 @default.
- W3120417475 hasConceptScore W3120417475C2779134260 @default.
- W3120417475 hasConceptScore W3120417475C2779261636 @default.
- W3120417475 hasConceptScore W3120417475C3007834351 @default.
- W3120417475 hasConceptScore W3120417475C3008058167 @default.
- W3120417475 hasConceptScore W3120417475C3018027319 @default.
- W3120417475 hasConceptScore W3120417475C32611913 @default.
- W3120417475 hasConceptScore W3120417475C524204448 @default.
- W3120417475 hasConceptScore W3120417475C71924100 @default.
- W3120417475 hasIssue "5" @default.
- W3120417475 hasLocation W31204174751 @default.
- W3120417475 hasLocation W31204174752 @default.
- W3120417475 hasLocation W31204174753 @default.
- W3120417475 hasOpenAccess W3120417475 @default.
- W3120417475 hasPrimaryLocation W31204174751 @default.
- W3120417475 hasRelatedWork W1972745941 @default.
- W3120417475 hasRelatedWork W2002414632 @default.
- W3120417475 hasRelatedWork W2043102346 @default.
- W3120417475 hasRelatedWork W2063036651 @default.
- W3120417475 hasRelatedWork W2108106476 @default.
- W3120417475 hasRelatedWork W2354672636 @default.
- W3120417475 hasRelatedWork W3134744114 @default.
- W3120417475 hasRelatedWork W3138694072 @default.
- W3120417475 hasRelatedWork W3186836045 @default.
- W3120417475 hasRelatedWork W3200879813 @default.
- W3120417475 hasVolume "61" @default.
- W3120417475 isParatext "false" @default.